| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3932420 | Fertility and Sterility | 2011 | 8 Pages |
Abstract
A beneficial effect of IVIG in treatment of RM was not observed. Given the absence of a proven mechanism of action, and the lack of a diagnostic algorithm to identify patients who are likely to benefit from such treatment, IVIG administration for treatment of recurrent miscarriage is not justified outside the context of properly designed RCTs.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Baris M.D., M.Sc., Seang Lin M.D., M.B.A., Fady M.B., B.Ch., M.Sc., Hananel M.D., William M.D.,